Carl Byers Archives - Mediformatica

CVS Health Ventures leads with Cobalt Ventures, F-Prime, Frist Cressey, and Autism Impact Fund
SpectrumAi, a company developing innovative solutions to improve autism care, today announced that it closed up to $20 million in Series…

What’s Inside Generative AI’s Brain?

Efficacy, Safety, and Cost-Effectiveness of “Internet + Pharmacy Care” Via the Alfalfa App in Warfarin Therapy Management After Cardiac Valve Replacement: Randomized Controlled Trial

News 5/21/25

Abundant Venture Partners unveils new platform for startups

Tag: Carl Byers

SpectrumAi Secures up to $20M Series A Investment

What’s Inside Generative AI’s Brain?

Efficacy, Safety, and Cost-Effectiveness of “Internet + Pharmacy Care” Via the Alfalfa App in Warfarin Therapy Management After Cardiac Valve Replacement: Randomized Controlled Trial

News 5/21/25

Abundant Venture Partners unveils new platform for startups

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

The government should invest now in healthcare cybersecurity, says HSCC

How Can Healthcare Organizations Create Self-Aware and Secure IT Networks?

Phase Scientific secures $34M and more digital health funding

A randomized controlled trial of a digital lifestyle intervention involving postoperative patients with colorectal cancer

Biostate AI Secures $12M to Optimize RNA Sequencing, Precision Medicine

MediFormatica

News Aggregator